Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CHNA

Loncar China Biopharma ETF (CHNA) Price, Holdings, & News

Loncar China Biopharma ETF logo

About Loncar China Biopharma ETF (NASDAQ:CHNA)

Key Stats

Today's Range
$13.53
$13.53
50-Day Range
$13.53
$14.77
52-Week Range
$13.35
$22.89
Volume
9 shs
Average Volume
538 shs
Market Capitalization
$10.56 million
Assets Under Management
$3.74 million
Dividend Yield
0.44%
Net Expense Ratio
0.79%
Aggregate Rating
N/A

ETF Overview

Loncar China Biopharma ETF Expenses

TypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.79%0.56%0.56%0.54%0.53%
Other Expenses0.00%0.47%0.56%0.52%0.56%
Total Expense0.79%0.75%0.76%0.73%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%
Net Expense0.79%0.60%0.63%0.63%0.60%
Receive CHNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHNA ETF News Headlines

Roundhill China Dragons ETF
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Liaoning Chengda Biotechnology Co. Ltd. A
See More Headlines

CHNA ETF - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Loncar China Biopharma ETF investors own include Alibaba Group (BABA), Baidu (BIDU), Nokia (NOK), AT&T (T), Tencent (TCEHY), Tesla (TSLA) and Advanced Micro Devices (AMD).

Fund Details

Issuer
Exchange Traded Concepts
Fund Name
Loncar China Biopharma ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:CHNA
Inception Date
8/14/2018
Fund Manager
Denise M. Krisko, Habib Moudachirou
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Loncar China BioPharma Index
Category
Sector
Focus
Health Care
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
89

Fund Statistics

Assets Under Management
$3.74 million
Average Daily Volume
$1.20 thousand
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Exchange Traded Concepts, LLC
Custodian
U.S. Bank, N.A.
Distributor
Quasar Distributors, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
GTS

Miscellaneous

Beta
0.95
Creation Unit
50,000
Creation Fee
$750.00
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Top 2 CHNA Holdings

  • US DOLLARS
    Holding Weight: 99.94%
  • DEPOSITS WITH BROKER FOR SHORT POSITIONS
    Holding Weight: 0.06%

This page (NASDAQ:CHNA) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners